Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GE Healthcare Expands Shanghai Fast Trak Training Center

Published: Monday, September 24, 2012
Last Updated: Monday, September 24, 2012
Bookmark and Share
Expansion adds IN Cell, Biacore and DeltaVision technologies for drug discovery and development.

GE Healthcare has announced the official opening of its expanded Fast Trak Training Center in Shanghai, China.

The opening ceremony was hosted by Kieran Murphy, CEO of GE Healthcare Life Sciences, and was attended by leading representatives from academia and the local biopharmaceutical and biotechnology industry.

GE Healthcare’s Fast Trak Training and Education Courses provide hands-on practical training in the latest technologies and strategies for start-to-finish bioprocessing, and are specifically designed to help manufacturers of biopharmaceuticals increase their process productivity and bring their product to market faster.

The company’s Fast Trak Training Centers, which are also located in Germany, India, Japan, Singapore, and the US, are equipped with the latest technologies for bioprocessing, in an environment that closely replicates the industrial setting.

GE Healthcare’s Fast Trak Training & Education team has over 20 years’ experience in providing training for bioprocess development and manufacturing.

By expanding the Fast Trak Center in Shanghai, GE Healthcare will be able to offer an increased number and variety of courses to meet the needs of the rapidly growing biopharmaceutical industry in China.

The extended Center has been equipped with several new GE Healthcare technologies such as IN Cell and DeltaVision™ for cellular imaging and Biacore™ and Microcal™ tools for protein interaction studies, allowing the company to offer, for the first time, training in some of the latest techniques used in drug discovery and development.

In addition to training, the Shanghai Fast Trak Center will also offer a full bioprocess development service to the industry, helping manufacturing professionals develop, optimize and refine their biopharmaceutical manufacturing processes for maximum productivity.

At the opening ceremony Mr Murphy also outlined GE Healthcare’s plans to launch an Educational Outreach Program for local university science students, in order to stimulate and encourage interest in the biopharmaceutical manufacturing industry.

Called Biotech “Future Stars” Training Program, the Outreach Program will be based on standard Fast Trak training courses and will be delivered by GE Healthcare scientists and sector experts.

Mr Murphy said, “I’m delighted to be opening our upgraded and expanded training facility here today. Bigger and better facilities will help us to offer a much higher level of support to the biopharmaceutical industry here in China. The Chinese government has identified the development of the biopharmaceutical industry as one of the pillar industries in the country’s 12th 5 year plan of state, and our new investments here in Shanghai are aligned with that.”

The Fast Trak Center is located within the GE China Technology Center (CTC), an integrated multi-disciplinary research campus with more than 1,500 researchers in over 60 laboratories researching breakthrough technologies in key areas such as energy, materials science and imaging technologies.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Investing in Cures for Cancer
GE’s acquisition of Biosafe Group SA further develops integrated cell therapy and regenerative medicine enabling development and patient access to innovative therapies.
Wednesday, July 13, 2016
GE Healthcare Expands European Capabilities
Expansion will see large volume sterile liquid handling capacity doubled.
Tuesday, April 12, 2016
BeiGene Selects GE’s FlexFactory™ Biomanufacturing Platform
Facility will manufacture biologics for clinical trials.
Wednesday, December 16, 2015
GE Healthcare Life Sciences and Promosome Sign Licensing Agreement
Innovative mammalian cell line development technologies that show promise for increasing manufacturing efficiency of vital biopharmaceuticals.
Tuesday, April 29, 2014
GE Acquires Strategic Assets from Thermo
GE to acquire cell culture media and sera, gene modulation and magnetic beads businesses.
Monday, January 06, 2014
GE Healthcare Launches Modular Biopharmaceutical Factory, KUBio
Innovative approach will save biopharmaceutical manufacturers time and money.
Tuesday, January 15, 2013
iBio, Inc. and GE Healthcare Form New Global Alliance
Companies to commercialize plant-based technologies for biopharmaceutical and vaccine manufacture.
Thursday, December 27, 2012
GE Healthcare Offers Fast Trak Training in Singapore
Fast Trak training and education courses provide practical training in the latest technologies and strategies for bioprocessing.
Tuesday, June 05, 2012
Karolinska University Hospital and GE Healthcare Collaborate to Advance Technologies for Cell Therapy
Pioneering three-year study will investigate technology and workflow needs in a clinical setting.
Wednesday, May 23, 2012
GE Healthcare to acquire Xcellerex Inc.
Addition of high growth company builds integrated, start-to-finish industry offering, focused on lowering costs, increasing productivity and reducing time to market.
Thursday, March 08, 2012
GE Healthcare and Neste Jacobs Form Strategic Alliance
Alliance will help healthcare providers worldwide increase access to life-saving treatments.
Tuesday, January 03, 2012
GE Healthcare and M+W Group Form Strategic Alliance in Vaccines, Insulin and Biopharmaceuticals
Companies to help emerging nations develop their own manufacturing capabilities for essential biopharmaceuticals, reducing reliance on imports.
Wednesday, December 14, 2011
NIBRT and GE Healthcare Announce Biopharmaceutical Research Collaboration
Joint research project to drive new technologies for the development and functional analysis of therapeutic antibodies.
Tuesday, October 04, 2011
GE Healthcare Appoints Kieran Murphy as Life Sciences CEO, Successor to Peter Ehrenheim
On 1 April 2011, Kieran Murphy will be promoted to succeed current Life Sciences President and CEO Peter Ehrenheim who will retire from GE after a transition period on July 31 2011.
Tuesday, February 22, 2011
G-CON Manufacturing and GE Healthcare Announce Intent to Collaborate in Developing Next Generation Modular Bio-therapeutic Manufacturing Technology
G-Con Manufacturing, LLC and GE Healthcare announce their intention to collaborate on the development of a modular portable bio-process manufacturing solution for vaccines and therapeutics.
Friday, December 03, 2010
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
NIH Launches Early-Stage Yellow Fever Vaccine Trial
Researchers at NIH have begun an early-stage clinical trial of an investigational vaccine designed to protect against yellow fever virus.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!